Holen Sie sich die Stockscreener-App
325.83
0.75%
-2.45
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$328.28
Offen:
$329.68
24-Stunden-Volumen:
1.39M
Relative Volume:
0.73
Marktkapitalisierung:
$73.37B
Einnahmen:
$194.82B
Nettoeinkommen (Verlust:
$5.53B
KGV:
13.33
EPS:
24.4514
Netto-Cashflow:
$3.77B
1W Leistung:
+2.53%
1M Leistung:
-7.03%
6M Leistung:
-12.95%
1J Leistung:
-19.95%
1-Tages-Spanne:
$320.40
$331.79
1-Wochen-Bereich:
$300.81
$332.66
52-Wochen-Spanne:
$273.71
$458.73
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Vergleichen Sie ELV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
325.83 | 72.96B | 194.82B | 5.53B | 3.77B | 24.45 |
|
UNH
Unitedhealth Group Inc
|
321.86 | 301.21B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
77.81 | 100.59B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
269.66 | 72.36B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
237.12 | 28.47B | 123.11B | 1.58B | 2.44B | 13.03 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-21 | Herabstufung | Argus | Buy → Hold |
| 2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Why Elevance Health Inc. (A58) stock is upgraded to buy2025 Analyst Calls & Risk Managed Investment Signals - newser.com
Why Elevance Health Inc. stock could rally stronglyPortfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Is Elevance Health Inc. stock inflation resilient2025 Price Action Summary & Long-Term Growth Plans - newser.com
Why Elevance Health Inc. stock attracts HNW investorsTrade Analysis Report & Risk Controlled Daily Trade Plans - newser.com
Is Elevance Health Inc. (A58) stock a top dividend aristocrat candidate2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Glenn Greenberg's Strategic Moves: Elevance Health Inc. Takes Center Stage with a 5. ... - Yahoo Finance
Is Elevance Health Inc. (A58) stock attractive for growth fundsTrade Entry Summary & Low Risk Entry Point Tips - newser.com
Will Elevance Health Inc. (A58) stock outperform Dow JonesGold Moves & High Accuracy Trade Alerts - newser.com
Published on: 2025-11-14 04:09:24 - newser.com
Can machine learning forecast Elevance Health Inc. recoveryJuly 2025 Macro Moves & AI Forecasted Stock Moves - newser.com
Will Elevance Health Inc. (A58) stock keep high P E multiplesTake Profit & Risk Adjusted Buy and Sell Alerts - newser.com
Is Elevance Health Inc. stock expanding market penetrationQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Will Elevance Health Inc. stock outperform foreign stocks2025 Breakouts & Breakdowns & Reliable Momentum Entry Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Elevance Health, Inc. (ELV) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Is Elevance Health Inc. stock a contrarian buyJuly 2025 News Drivers & AI Powered Market Entry Ideas - newser.com
Analyzing Elevance Health Inc. with risk reward ratio chartsTrade Analysis Summary & Weekly Stock Breakout Alerts - newser.com
How risky is Elevance Health Inc. stock compared to peersPortfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com
Elevance Seeks to Keep NYC Contract in Secretive Legal Fight - Bloomberg.com
Why Elevance Health Inc. stock is rated strong buyWeekly Market Report & AI Optimized Trade Strategies - newser.com
How Elevance Health Inc. stock compares with top peersWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-11-12 17:20:34 - newser.com
Elevance Health Inc. stock outperforms competitors on strong trading day - MSN
Will Elevance Health Inc. stock deliver consistent dividendsEarnings Growth Summary & Weekly Market Pulse Updates - newser.com
Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know - Finviz
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elevance Health, Inc. (ELV) And Encourages Shareholders to Connect - ACCESS Newswire
Here’s Why Madison Large Cap Fund Sold Elevance Health (ELV) in Q3 - Insider Monkey
Is it time to cut losses on Elevance Health Inc.Quarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
Did Elevance Health's (ELV) Reaffirmed 2025 Outlook Signal Operational Stability Amid Industry Pressures? - Yahoo Finance
How Elevance Health Inc. (A58) stock correlates with oil markets2025 Geopolitical Influence & Daily Chart Pattern Signals - newser.com
Is Elevance Health Inc. stock ready for a breakoutMarket Volume Summary & Expert Curated Trade Setups - newser.com
Elevance Health (ELV) Reaffirms 2025 Earnings Guidance Amid Inve - GuruFocus
Elevance Health Reaffirms 2025 Earnings Guidance - TipRanks
Elevance Health reaffirms 2025 earnings guidance at $24.70 per shareSEC filing - MarketScreener
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):